Cargando…

Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2 negative patients with early onset breast cancer

PURPOSE: Clinical testing for germline variation in multiple cancer susceptibility genes is available using massively parallel sequencing. Limited information is available for pre-test genetic counseling regarding the spectrum of mutations and variants of uncertain significance (VUSs) in defined pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maxwell, Kara N., Wubbenhorst, Bradley, D’Andrea, Kurt, Garman, Bradley, Long, Jessica M., Powers, Jacquelyn, Rathbun, Katherine, Stopfer, Jill E., Zhu, Jiajun, Bradbury, Angela R., Simon, Michael S., DeMichele, Angela, Domchek, Susan M., Nathanson, Katherine L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465412/ https://www.ncbi.nlm.nih.gov/pubmed/25503501 http://dx.doi.org/10.1038/gim.2014.176

Ejemplares similares

Biallelic BRCA Loss and Homologous Recombination Deficiency in Nonbreast/Ovarian Tumors in Germline BRCA1/2 Carriers
por: Wineland, Dylane, et al.
Publicado: (2023)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017)

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
por: Slavin, Thomas P., et al.
Publicado: (2017)

Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers
por: Shah, Jennifer B., et al.
Publicado: (2022)

Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
por: Slavin, Thomas P., et al.
Publicado: (2017)

Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Rebbeck, Timothy R, et al.
Publicado: (2008)

Common breast cancer risk variants in the post-COGS era: a comprehensive review
por: Maxwell, Kara N, et al.
Publicado: (2013)

Research participants’ experiences with return of genetic research results and preferences for web‐based alternatives
por: Gaieski, Jill B., et al.
Publicado: (2019)

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Metcalfe, K, et al.
Publicado: (2011)

Using a Machine Learning Approach to Identify Low-Frequency and Rare FLG Alleles Associated with Remission of Atopic Dermatitis
por: Berna, Ronald, et al.
Publicado: (2021)

Current approaches to the management of Her2-negative metastatic breast cancer
por: Gogineni, Keerthi, et al.
Publicado: (2012)

Paclitaxel is necessary for improved survival in epithelial ovarian cancers with homologous recombination gene mutations
por: Jean, Stephanie, et al.
Publicado: (2016)

Trastuzumab deruxtecan: An antibody-drug conjugate embracing its destiny in breast cancer
por: Makhlin, Igor, et al.
Publicado: (2022)

Rapid detection of BRCA1/2 recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels
por: Kwong, Ava, et al.
Publicado: (2017)

DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3
por: Yang, Rachel L., et al.
Publicado: (2015)

BRCA1/2 Mutations and Cardiovascular Function in Breast Cancer Survivors
por: Demissei, Biniyam G., et al.
Publicado: (2022)

Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer
por: Makhlin, Igor, et al.
Publicado: (2022)

Blood Arsenic Levels as a Marker of Breast Cancer Risk among BRCA1 Carriers
por: Marciniak, Wojciech, et al.
Publicado: (2021)

Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction
por: Demissei, Biniyam G., et al.
Publicado: (2020)

Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation
por: Wattenberg, Max M., et al.
Publicado: (2019)

Clinical Impact of Pathogenic Variants in DNA Damage Repair Genes beyond BRCA1 and BRCA2 in Breast and Ovarian Cancer Patients
por: Espinel, Whitney, et al.
Publicado: (2022)

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
por: Kuchenbaecker, Karoline B, et al.
Publicado: (2014)

Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior BRCA1/2 Probability
por: Evans, D. Gareth, et al.
Publicado: (2021)

Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer
por: Muranen, Taru A., et al.
Publicado: (2020)

Phase 1 trial of olaparib and oral cyclophosphamide in BRCA breast cancer, recurrent BRCA ovarian cancer, non-BRCA triple-negative breast cancer, and non-BRCA ovarian cancer
por: Lee, Chee Khoon, et al.
Publicado: (2019)

BRCA Mutations and Breast Cancer Prevention
por: Kotsopoulos, Joanne
Publicado: (2018)

Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers
por: Neuhausen, Susan L, et al.
Publicado: (2009)

Analysis of BRCA1- and BRCA2-Related Pancreatic Cancer and Survival
por: Boursi, Ben, et al.
Publicado: (2023)

Gastric Cancer Risk and Pathogenesis in BRCA1 and BRCA2 Carriers
por: Buckley, Kole H., et al.
Publicado: (2022)

Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA
por: Piombino, Claudia, et al.
Publicado: (2020)

Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer
por: Kemp, Zoe, et al.
Publicado: (2019)

Genome instability in blood cells of a BRCA1+ breast cancer family
por: Xiao, Fengxia, et al.
Publicado: (2014)

Racial and Ethnic Differences in BRCA1/2 and Multigene Panel Testing Among Young Breast Cancer Patients
por: Jones, T, et al.
Publicado: (2019)

NGS Panel Testing of Triple-Negative Breast Cancer Patients in Cyprus: A Study of BRCA-Negative Cases
por: Zanti, Maria, et al.
Publicado: (2020)

Breast cancer in young women
por: Gabriel, Courtney A, et al.
Publicado: (2010)

Associations between breast density and a panel of single nucleotide polymorphisms linked to breast cancer risk: a cohort study with digital mammography
por: Keller, Brad M, et al.
Publicado: (2015)

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
por: Warner, Ellen
Publicado: (2018)

BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients
por: Yazici, H, et al.
Publicado: (2000)

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families
por: Eerola, Hannaleena, et al.
Publicado: (2005)

Screening for germline rearrangements in BRCA1 and BRCA2 in Norwegian families with breast or breast/ovarian cancer
por: Van Ghelue, M, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_fbatsoornu348s6rqlm7eq7or4